ISHARES TR's ticker is IBB and the CUSIP is 464287556. A total of 846 filers reported holding ISHARES TR in Q1 2021. The put-call ratio across all filers is 2.45 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,588,026 | -3.8% | 21,163 | -0.1% | 0.58% | -2.7% |
| Q2 2023 | $2,689,397 | -1.5% | 21,183 | +0.2% | 0.59% | -9.3% |
| Q1 2023 | $2,730,575 | -1.9% | 21,141 | -0.3% | 0.66% | -6.7% |
| Q4 2022 | $2,784,794 | +13.9% | 21,211 | +1.4% | 0.70% | +4.6% |
| Q3 2022 | $2,446,000 | +6.3% | 20,910 | +6.9% | 0.67% | +15.3% |
| Q2 2022 | $2,301,000 | +294.7% | 19,565 | +412.2% | 0.58% | +561.4% |
| Q4 2021 | $583,000 | +269.0% | 3,820 | +291.8% | 0.09% | +158.8% |
| Q3 2021 | $158,000 | +159.0% | 975 | +163.5% | 0.03% | +183.3% |
| Q2 2021 | $61,000 | +8.9% | 370 | 0.0% | 0.01% | -7.7% |
| Q1 2021 | $56,000 | 0.0% | 370 | 0.0% | 0.01% | 0.0% |
| Q4 2020 | $56,000 | +12.0% | 370 | 0.0% | 0.01% | -7.1% |
| Q3 2020 | $50,000 | +66.7% | 370 | +34.5% | 0.01% | +16.7% |
| Q1 2020 | $30,000 | -9.1% | 275 | 0.0% | 0.01% | +50.0% |
| Q4 2019 | $33,000 | -38.9% | 275 | -49.1% | 0.01% | -69.2% |
| Q3 2019 | $54,000 | – | 540 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Elliott Investment Management L.P. | 4,617,600 | $564,686,304 | 4.37% |
| BOULDER HILL CAPITAL MANAGEMENT LP | 57,250 | $7,001,103 | 4.35% |
| DAFNA Capital Management LLC | 102,500 | $12,534,725 | 3.90% |
| Michelson Medical Research Foundation, Inc. | 43,395 | $5,306,775 | 3.58% |
| Rye Brook Capital LLC | 40,900 | $5,002 | 3.56% |
| Bronte Capital Management Pty Ltd. | 283,229 | $34,636,074 | 3.49% |
| FWL INVESTMENT MANAGEMENT, LLC | 39,504 | $4,830,944 | 3.24% |
| Alpha Family Trust | 34,568 | $4,227,321 | 3.22% |
| HARBOUR INVESTMENT MANAGEMENT LLC | 40,720 | $4,985,830 | 2.85% |
| CUMBERLAND ADVISORS INC | 51,490 | $6,296,712 | 2.79% |